P4 Medicine: the Future Around the Corner

Sobradillo, Patricia; Pozo, Francisco; Agustí, Álvar

doi:10.1016/S1579-2129(11)70006-4

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is a scientific journal that preferentially publishes prospective original research articles whose content is based upon results dealing with several aspects of respiratory diseases such as epidemiology, pathophysiology, clinics, surgery, and basic investigation. Other types of articles such as reviews, editorials, a few special articles of interest to the society and the editorial board, scientific letters, letters to the Editor, and clinical images are also published in the Journal. It is a monthly Journal that publishes a total of 12 issues and a few supplements, which contain articles belonging to the different sections.

All the manuscripts received in the Journal are evaluated by the Editors and sent to expert peer-review while handled by the Editor and/or an Associate Editor from the team. The Journal is published monthly in English.

Manuscripts will be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/, link which is also accessible through the main web page of Archivos de Bronconeumologia.

Access to any published article, is possible through the Journal's web page as well as from PubMed, Science Direct, and other international databases. Furthermore, the Journal is also present in Twitter and Facebook. The Journal expresses the voice of the Spanish Respiratory Society of Pulmonology and Thoracic Surgery (SEPAR) as well as that of other scientific societies such as the Latin American Thoracic Society (ALAT) and the Iberian American Association of Thoracic Surgery (AICT).

Authors are also welcome to submit their articles to the Journal's open access companion title, Open Respiratory Archives.

Archivos de Bronconeumologia has received the new Impact Factor (JCR). The impact factor has risen from 6.333 in 2021 to 8 in the last evaluated year, 2022.
It is needed to be a member of SEPAR or have a subscription to access full texts of articles published last year. Abstracts are available for all visitors.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

2.8

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.434

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.437

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 47. Issue 1.

Pages 35-40 (January 2011)

More article options

Pages 35-40 (January 2011)

Review

DOI: 10.1016/S1579-2129(11)70006-4

Full text access

P4 Medicine: the Future Around the Corner

Isoenzimas de lactatodeshidrogenasa en el músculo esquelético de pacientes con EPOC

Visits

7297

Download PDF

Patricia Sobradilloa,b,c,

Corresponding author

psobradillo@ciberes.org

Corresponding author.

, Francisco Pozoa,d, Álvar Agustía,b,c,e

a Ciber en Enfermedades Respiratorias (CIBERES), Barcelona, Spain

b Instituto del Tórax, Hospital Clínic, Universidad de Barcelona, Spain

c Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

d Hospital 12 de Octubre, Madrid, Spain

e Fundación Caubet Cimera, Mallorca, Spain

This item has received

7297 Visits

Article information

Abstract

Bibliography

Download PDF

Statistics

Abstract

Traditional medical practice has always been “reactive”, meaning that the doctor intervenes when there is disease. Theoretical (scale-free networks and complex systems), technological (highly efficient “omic” technologies) and conceptual (systems biology) advances of the last decade prelude the transition towards “anticipatory” medicine centered on health and not disease. This review establishes the fundamental conceptual bases and discusses the principal aspects of this new medicine, known as “P4 Medicine” as it is personalized, predictive, preventive and participatory.

Keywords:

Systems biology

Genetics

Research

Scale-free networks

Systems biology

Resumen

La práctica médica tradicional ha sido “reactiva” (el médico interviene cuando hay enfermedad). Los avances teóricos (redes libres de escala y sistemas complejos), tecnológicos (tecnologías “ómicas” de alta eficiencia) y conceptuales (biología de sistemas) habidos en la última década permiten anticipar la transición hacia una medicina “anticipatoria”, centrada en la salud (no en la enfermedad). Esta revisión establece las bases conceptuales fundamentales y discute los principales aspectos de esta nueva medicina, denominada “Medicina P4” por ser personalizada, predictiva, preventiva y participatoria.

Palabras clave:

Biología de sistemas

Genética

Investigación

Redes libres de escala

Sistemas complejo

Full text is only aviable in PDF

References

[1.]

J.C. Venter, M.D. Adams, E.W. Myers, P.W. Li, R.J. Mural, G.G. Sutton, et al.

The sequence of the human genome.

Science, 291 (2001), pp. 1304-1351

http://dx.doi.org/10.1126/science.1058040 | Medline

[2.]

L.H. Hartwell, J.J. Hopfield, S. Leibler, A.W. Murray.

From molecular to modular cell biology.

Nature, 402 (1999), pp. C47-C52

http://dx.doi.org/10.1038/35011540 | Medline

[3.]

A.L. Barabasi, Z.N. Oltvai.

Network biology: understanding the cell’s functional organization.

Nat Rev Genet, 5 (2004), pp. 101-113

http://dx.doi.org/10.1038/nrg1272 | Medline

[4.]

L. Hood, L. Rowen, D.J. Galas, J.D. Aitchison.

Systems biology at the Institute for Systems Biology.

Brief Funct Genomic Proteomic, 7 (2008), pp. 239-248

http://dx.doi.org/10.1093/bfgp/eln027 | Medline

[5.]

B. Bollobás.

Graph. Theory: an Introductory Course.

Springer Verlag, (1979),

[6.]

R. Albert, A.L. Barabasi.

Statistical mechanics of complex networks.

Rev Mod Phys, 74 (2002), pp. 47-97

[7.]

Barabasi AL. Linked: How Everything Is Connected to Everything Else and What it Means for Business, Science, and Everyday Life. Perseus Books, 2002.

[8.]

R. Pastor-Satorras, A. Vespignani.

Epidemic spreading in scale-free networks.

Phys Rev Lett, 86 (2001), pp. 3200-3203

http://dx.doi.org/10.1103/PhysRevLett.86.3200 | Medline

[9.]

S. Eubank, H. Guclu, V.S. Kumar, M.V. Marathe, A. Srinivasan, Z. Toroczkai, et al.

Modelling disease outbreaks in realistic urban social networks.

Nature, 429 (2004), pp. 180-184

http://dx.doi.org/10.1038/nature02541 | Medline

[10.]

R. Pastor-Satorras, A. Vespignani.

Immunization of complex networks.

Phys Rev E Stat Nonlin Soft Matter Phys, 65 (2002),

http://dx.doi.org/10.1103/PhysRevE.65.066605 | Medline

[11.]

Z. Dezso, A.L. Barabasi.

Halting viruses in scale-free networks.

Phys Rev E Stat Nonlin Soft Matter Phys, 65 (2002),

http://dx.doi.org/10.1103/PhysRevE.65.066605 | Medline

[12.]

A. Ergun, C.A. Lawrence, M.A. Kohanski, T.A. Brennan, J.J. Collins.

A network biology approach to prostate cancer.

Mol Syst Biol, 3 (2007), pp. 82

http://dx.doi.org/10.1038/msb4100125 | Medline

[13.]

X. Lu, V.V. Jain, P.W. Finn, D.L. Perkins.

Hubs in biological interaction networks exhibit low changes in expression in experimental asthma.

Mol Syst Biol, 3 (2007), pp. 98

http://dx.doi.org/10.1038/msb4100138 | Medline

[14.]

N.E. Alexis, J.C. Lay, M. Almond, D.B. Peden.

Inhalation of low-dose endotoxin favors local T(H)2 response and primes airway phagocytes in vivo.

J Allergy Clin Immunol, 114 (2004), pp. 1325-1331

http://dx.doi.org/10.1016/j.jaci.2004.09.002 | Medline

[15.]

N.A. Christakis, J.H. Fowler.

The spread of obesity in a large social network over 32 years.

N Engl J Med, 357 (2007), pp. 370-379

http://dx.doi.org/10.1056/NEJMsa066082 | Medline

[16.]

N.A. Christakis, J.H. Fowler.

The collective dynamics of smoking in a large social network.

N Engl J Med, 358 (2008), pp. 2249-2258

http://dx.doi.org/10.1056/NEJMsa0706154 | Medline

[17.]

A.L. Barabasi.

Network medicine–from obesity to the “diseasome”.

N Engl J Med, 357 (2007), pp. 404-407

http://dx.doi.org/10.1056/NEJMe078114Article | Medline

[18.]

J. Lim, T. Hao, C. Shaw, A.J. Patel, G. Szabo, J.F. Rual, et al.

A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.

Cell, 125 (2006), pp. 801-814

http://dx.doi.org/10.1016/j.cell.2006.03.032 | Medline

[19.]

K.I. Goh, M.E. Cusick, D. Valle, B. Childs, M. Vidal, A.L. Barabasi.

The human disease network.

Proc Natl Acad Sci U S A, 104 (2007), pp. 8685-8690

http://dx.doi.org/10.1073/pnas.0701361104 | Medline

[20.]

J. Loscalzo, I. Kohane, A.L. Barabasi.

Human disease classification in the postgenomic era: a complex systems approach to human pathobiology.

Mol Syst Biol, 3 (2007), pp. 124

http://dx.doi.org/10.1038/msb4100163 | Medline

[21.]

N.M. Morel, J.M. Holland, J. Van der Greef, E.W. Marple, C. Clish, J. Loscalzo, et al.

Primer on medical genomics. Part XIV: Introduction to systems biology?a new approach to understanding disease and treatment.

Mayo Clin Proc, 79 (2004), pp. 651-658

http://dx.doi.org/10.1016/S0025-6196(11)62287-8 | Medline

[22.]

J.K. Nicholson.

Global systems biology, personalized medicine and molecular epidemiology.

Mol Syst Biol, 2 (2006), pp. 52

http://dx.doi.org/10.1038/msb4100095 | Medline

[23.]

H. Kitano.

A robustness-based approach to systems-oriented drug design.

Nat Rev Drug Discov, 6 (2007), pp. 202-210

http://dx.doi.org/10.1038/nrd2195 | Medline

[24.]

C.A. Hidalgo, N. Blumm, A.L. Barabasi, N.A. Christakis.

A dynamic network approach for the study of human phenotypes.

PLoS Comput Biol, 5 (2009),

http://dx.doi.org/10.1371/journal.pcbi.1000509 | Medline

[25.]

D.J. Galas, L. Hood.

Systems Biology and Emerging Technologies Will Catalyze the Transition from Reactive Medicine to Predictive, Personalized. Preventive and Participatory (P4) Medicine.

IBC, 1 (2009), pp. 1-4

[26.]

M.K. Han, A. Agusti, P.M. Calverley, B.R. Celli, G. Criner, J.L. Curtis, et al.

Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD.

Am J Respir Crit Care Med, 182 (2010), pp. 598-604

http://dx.doi.org/10.1164/rccm.200912-1843CC | Medline

Indexed in:

Follow us:

Subscribe:

Subscribe to our newsletter